SCHEMBL30484336

SCHEMBL30484336

COC(=O)N1CC2(CCNCC2)C1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.45
CYP2C9 P11712 5/20 0.45
CYP2D6 P10635 5/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP3A4 P08684 7/20 0.44
CYP2C19 P33261 4/20 0.44
USP2 O75604 4/20 0.44
HSD17B10 Q99714 3/20 0.43
CHRNB2 P17787 2/20 0.43
CHRNA4 P43681 2/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
TSHR P16473 2/20 0.41
ALOX15 P16050 1/20 0.41
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30543258 0.89 USP2 (0.41) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
Trifluoroacetic Acid SCHEMBL30184135 0.89 CYP3A4 (0.43) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
SCHEMBL18812838 0.83 CYP1A2 (0.58) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
SCHEMBL29424710 0.82 CYP2C9 (0.57) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
SCHEMBL30745944 0.82 CYP2C9 (0.57) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
SCHEMBL18389861 0.81 OPRM1 (0.42) CYP1A2CYP2D6ALDH1A1CYP3A4CYP2C19
SCHEMBL30335554 0.81 CYP2C9 (0.50) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
SCHEMBL484569 0.80 ACACB (0.43) CYP1A2USP2
SCHEMBL20669401 0.80 CYP1A2 (0.44) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4
SCHEMBL21358327 0.80 CHRNB2 (0.47) CYP1A2CYP2C9CYP2D6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024182447-A1 COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K VIVIDION THERAPEUTICS, INC. (US) 2024-09-06 WO disclosed
CN-112110918-B Spiro substituted pyrimido cyclic compounds, process for their preparation and their use in medicine 劲方医药科技(上海)有限公司 2023-08-22 CN disclosed
CN-112010858-B BTK inhibitor, preparation method and pharmaceutical application thereof 四川海思科制药有限公司 2023-07-18 CN disclosed
CN-112142748-B Pyrazolopyrimidine compound, and preparation method and application thereof 上海医药集团股份有限公司 2023-07-04 CN disclosed